Try our corporate solution for free!
(212) 419-8286

Gout therapeutics market value U.S. by drug type 2015-2025

This statistic shows the value of the gout therapeutics market in the United States from 2015 to 2025, by drug type. In 2015, urate lowering agents to treat gout were worth nearly 270 million U.S. dollars. It is forecasted that it will exceed 1.3 billion U.S. dollars by 2025.

Gout therapeutics market in the U.S. from 2015 to 2025, by drug type

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until March 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2019


United States

Survey time period

March 2017

Supplementary notes

* Non-steroidal anti-inflammatory drugs.
** Figures from 2016 on are forecasts.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.